Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice
- PMID: 11353640
- PMCID: PMC90560
- DOI: 10.1128/AAC.45.6.1872-1875.2001
Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice
Abstract
In both scid and BALB/c mouse-Leishmania donovani models, hexadecyphosphocholine (miltefosine) and AmBisome had similar levels of activity. In contrast, sodium stibogluconate (Pentostam) was significantly less active against L. donovani in scid mice than in BALB/c mice. The in vitro anti-leishmanial activity of miltefosine was similar in peritoneal macrophages derived from both scid and BALB/c mice, whereas Pentostam and AmBisome were significantly more active in the latter.
Figures
Similar articles
-
In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.Antimicrob Agents Chemother. 2009 Feb;53(2):835-8. doi: 10.1128/AAC.01233-08. Epub 2008 Nov 17. Antimicrob Agents Chemother. 2009. PMID: 19015344 Free PMC article.
-
In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.Antimicrob Agents Chemother. 2006 Jan;50(1):73-9. doi: 10.1128/AAC.50.1.73-79.2006. Antimicrob Agents Chemother. 2006. PMID: 16377670 Free PMC article.
-
Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.Exp Parasitol. 2006 Dec;114(4):247-52. doi: 10.1016/j.exppara.2006.03.016. Epub 2006 May 23. Exp Parasitol. 2006. PMID: 16716301
-
[Treatment of visceral leishmaniasis in children].Med Trop (Mars). 2007 Feb;67(1):73-8. Med Trop (Mars). 2007. PMID: 17506279 Review. French.
-
[Treatment of visceral leishmaniasis: efficacy and limits of miltefosine].Sante. 2001 Oct-Dec;11(4):257-8. Sante. 2001. PMID: 11861203 Review. French. No abstract available.
Cited by
-
Is Visceral Leishmaniasis the same in HIV-coinfected adults?Braz J Infect Dis. 2018 Mar-Apr;22(2):92-98. doi: 10.1016/j.bjid.2018.03.001. Epub 2018 Mar 27. Braz J Infect Dis. 2018. PMID: 29601790 Free PMC article.
-
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.Nature. 2018 Aug;560(7717):192-197. doi: 10.1038/s41586-018-0356-z. Epub 2018 Jul 25. Nature. 2018. PMID: 30046105 Free PMC article.
-
A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.Am J Trop Med Hyg. 2011 Jan;84(1):109-17. doi: 10.4269/ajtmh.2011.10-0437. Am J Trop Med Hyg. 2011. PMID: 21212212 Free PMC article.
-
Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant.Microorganisms. 2021 Oct 29;9(11):2253. doi: 10.3390/microorganisms9112253. Microorganisms. 2021. PMID: 34835379 Free PMC article.
-
Use of antimony in the treatment of leishmaniasis: current status and future directions.Mol Biol Int. 2011;2011:571242. doi: 10.4061/2011/571242. Epub 2011 Jun 8. Mol Biol Int. 2011. PMID: 22091408 Free PMC article.
References
-
- Arthur G, Bittman R. The inhibition of cell signaling pathways by antitumor ether lipids. Biochim Biophys Acta. 1998;1390:85–102. - PubMed
-
- Berman J D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997;24:684–703. - PubMed
-
- Bosma G C, Custer R P, Bosma M J. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301:527–530. - PubMed
-
- Breiser A, Kim D J, Fleer E A, Damenz W, Drube A, Berger M, Nagel G A, Eibl H, Unger C. Distribution and metabolism of hexadecylphosphocholine in mice. Lipids. 1987;22:925–926. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical